Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0529 Transporter Info | ||||
Gene Name | SCN9A | ||||
Transporter Name | Voltage-gated sodium channel alpha Nav1.7 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [1] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Tissue |
Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
MYC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in AK7 condition | [2] | ||||
TF Protein Name |
Myc proto-oncogene protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Myc proto-oncogene protein (MYC) has been reported to bind to the transcription of SCN9A gene in AK7 condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
USF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SCN9A gene in nervous system lesion condition | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) has been reported to repress the transcription of SCN9A gene in nervous system lesion condition, which leads to a decreased expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in health condition | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SCN9A gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
PPARD |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Repression of SCN9A gene in myofibroblasts condition | [5] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SCN9A gene in myofibroblasts condition, which leads to a decreased expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Transcriptional Phenomenon2 |
Repression of SCN9A gene in breast cancer condition | [6] | ||||
TF Protein Name |
Peroxisome proliferator-activated receptor delta | Transcription Factor Info | ||||
Affected Drug/Substrate |
ST247 and DG172 | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Down regulating | |||||
Detailed Description |
Peroxisome proliferator-activated receptor delta (PPARD) has been reported to repress the transcription of SCN9A gene in breast cancer condition, which leads to a decreased expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in megakaryocytes condition | [7] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Erythroid transcription factor (GATA1) has been reported to bind to the transcription of SCN9A gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Transcriptional Phenomenon2 |
Direct binding to SCN9A gene | [8] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
KLF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [1] | ||||
TF Protein Name |
Krueppel-like factor 4 | Transcription Factor Info | ||||
Tissue |
Foreskin; Pancreatic ductal; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 4 (KLF4) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [9] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Tissue |
Colon; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [10] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in health condition | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SCN9A gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [9] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Mesenchymal; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SCN9A gene | [10] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Bone marrow; Pancreatic ductal | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SCN9A gene, which in turn affects the expression or function of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP63 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in epithelial to mesenchymal transition condition | [11] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SCN9A gene in epithelial to mesenchymal transition condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Transcriptional Phenomenon2 |
Binding to SCN9A gene in health condition | [12] | ||||
TF Protein Name |
Tumor protein 63 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Tumor protein 63 (TP63) has been reported to bind to the transcription of SCN9A gene in health condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in megakaryocytes condition | [7] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SCN9A gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
TF Superclass7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SMAD4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SCN9A gene in epithelial ovarian cancer condition | [13] | ||||
TF Protein Name |
Mothers against decapentaplegic homolog 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Mothers against decapentaplegic homolog 4 (SMAD4) has been reported to bind to the transcription of SCN9A gene in epithelial ovarian cancer condition, which leads to an affected expression of the drug transporter Voltage-gated sodium channel alpha Nav1.7. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.